Guardant Health, Inc. (GH) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
GH EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GH Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 64.5% | -44.5% | -42.4% |
| 2024 | 60.8% | -60.0% | -59.0% |
| 2023 | 59.7% | -100.1% | -85.0% |
| 2022 | 65.2% | -121.1% | -145.6% |
| 2021 | 67.1% | -110.0% | -108.6% |
Download Data
Export GH earnings history in CSV or JSON format
Free sign-in required to download data
Guardant Health, Inc. (GH) Earnings Overview
As of May 6, 2026, Guardant Health, Inc. (GH) reported trailing twelve-month net income of -$399M, reflecting +6.7% year-over-year growth. The company earned $-3.18 per diluted share over the past four quarters, with a net profit margin of -42.4%.
Looking at the long-term picture, GH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$46M in fiscal 2016.
Guardant Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), ILMN ($853M net income, 19.6% margin), NTRA (-$309M net income, -11.2% margin), GH has room to improve margins relative to the peer group. Compare GH vs EXAS →
GH Earnings vs Peers
Earnings metrics vs comparable public companies
GH Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$416M | +4.6% | -$437M | $-3.32 | -42.4% | -44.5% |
| 2024 | -$436M | +9.0% | -$444M | $-3.56 | -59.0% | -60.0% |
| 2023 | -$479M | +26.8% | -$565M | $-4.28 | -85.0% | -100.1% |
| 2022 | -$655M | -61.4% | -$544M | $-6.41 | -145.6% | -121.1% |
| 2021 | -$406M | -59.8% | -$411M | $-3.80 | -108.6% | -110.0% |
| 2020 | -$254M | -235.5% | -$255M | $-2.53 | -88.5% | -88.9% |
| 2019 | -$76M | +11.1% | -$82M | $-0.75 | -35.3% | -38.4% |
| 2018 | -$85M | -2.2% | -$93M | $-1.00 | -93.8% | -102.5% |
| 2017 | -$83M | -80.4% | -$77M | $-1.18 | -167.0% | -153.7% |
| 2016 | -$46M | - | -$44M | $-3.49 | -182.7% | -173.7% |
Full GH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See GH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGH — Frequently Asked Questions
Quick answers to the most common questions about buying GH stock.
Is GH growing earnings?
GH EPS stands at $-3.18, with +6.7% growth matching the 5-year CAGR of N/A. TTM net income is $-399M. Earnings trajectory remains consistent.
What are GH's profit margins?
Guardant Health, Inc. net margin is -42.4%, with operating margin at -44.5%. Below-average margins reflect competitive or cost pressures.
How consistent are GH's earnings?
GH earnings data spans 2016-2025. The current earnings trend is +6.7% YoY. Historical data enables comparison across business cycles.